Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial is a research paper published in JMIR Formative Research (2023). On theSindex it has a DataRank of 0.339. It has been cited 6 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0469
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
NIDA NIH HHS
Grant: K99 DA046564
NIDA NIH HHS
Grant: R00 DA046564
NIDA NIH HHS
Grant: T32 DA007292
NCI NIH HHS
Grant: P30 CA225520
National Institutes of Health
Grant: 5T32DA007292-20
NIDA Epidemiology Training Program: Johns Hopkins University
National Institutes of Health
Grant: 5K99DA046564-02
Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation
National Institutes of Health
Grant: 3P30CA225520-06S4
Stephenson Cancer Center - Cancer Center Support Grant
FWCI
0.95
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals